Findings

What do systematic reviews say?

2 questions · 2 findings · 1 reviews · Acute Respiratory Infections

No studies found 0 · 0%GRADE not reported 1 · 50%Very low 0 · 0%Low 0 · 0%Moderate 1 · 50%High 0 · 0%

Supplemental oxygen therapy for RSV infection · patients at high risk of severe respiratory syncytial virus infection

Palivizumab showed no clear difference in supplemental oxygen therapy for RSV infection compared with motavizumab (moderate certainty).

1 finding from 1 review

Monoclonal antibody for reducing the risk of respiratory syncytial virus infection in children 2013 · Cochrane Headline outcomes only
RR 1.49 [0.98, 2.26]
2 studies · 7870 participants
Moderate

Supplemental oxygen therapy for RSV infection · patients at high risk of severe respiratory syncytial virus infection

1 finding from 1 review

Monoclonal antibody for reducing the risk of respiratory syncytial virus infection in children 2013 · Cochrane Headline outcomes only
no estimate extracted
0 studies · 0 participants
GRADE not reported